NYSE: JNJJohnson & Johnson Revenue
Johnson & Johnson revenue was $92.15B for the trailing 12 months ending Sep 28, 2025, with 73% growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 28, 2025 was $24.0B, up 1.1% from last quarter. For the last reported fiscal year 2024 ending Dec 29, 2024, JNJ annual revenue was $88.8B, with 4.3% growth year-over-year.
JNJ past revenue growth
How has JNJ's revenue growth performed historically?
Company
5.08%
Industry
15.53%
Market
19.58%
JNJ's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
JNJ's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
JNJ's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
JNJ revenue history
Current Revenue
$92.1B
Current Earnings
$25.1B
Current Profit Margin
27.3%
JNJ's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance
Be the first to know when JNJ announces revenue.
JNJ Revenue History By Year
| JNJ Yearly Revenue | JNJ Revenue | JNJ Change | JNJ Revenue Growth |
|---|---|---|---|
| 2024-12-29 | $88.82B | $3.66B | +4.30% |
| 2023-12-31 | $85.16B | $5.17B | +6.46% |
| 2023-01-01 | $79.99B | $1.25B | +1.59% |
| 2022-01-02 | $78.74B | -$3.84B | -4.65% |
| 2021-01-03 | $82.58B | $525.00M | +0.64% |
| 2019-12-29 | $82.06B | $478.00M | +0.59% |
| 2018-12-30 | $81.58B | $5.13B | +6.71% |
| 2017-12-31 | $76.45B | $4.56B | +6.34% |
| 2017-01-01 | $71.89B | $1.82B | +2.59% |
| 2016-01-03 | $70.07B | -$4.26B | -5.73% |
| 2014-12-28 | $74.33B | $3.02B | +4.23% |
| 2013-12-29 | $71.31B | $4.09B | +6.08% |
| 2012-12-30 | $67.22B | $2.19B | +3.37% |
| 2012-01-01 | $65.03B | $3.44B | +5.59% |
| 2011-01-02 | $61.59B | -$310.00M | -0.50% |
| 2010-01-03 | $61.90B | -$1.85B | -2.90% |
| 2008-12-28 | $63.75B | $2.65B | +4.34% |
| 2007-12-30 | $61.10B | $7.77B | +14.57% |
| 2006-12-31 | $53.32B | $2.81B | +5.56% |
| 2006-01-01 | $50.51B | $3.17B | +6.69% |
| 2005-01-02 | $47.35B | $5.49B | +13.10% |
| 2003-12-28 | $41.86B | $5.56B | +15.33% |
| 2002-12-29 | $36.30B | $3.98B | +12.32% |
| 2001-12-30 | $32.32B | $3.15B | +10.78% |
| 2000-12-31 | $29.17B | $1.17B | +4.16% |
| 2000-01-02 | $28.01B | $4.01B | +16.72% |
| 1999-01-03 | $24.00B | $1.17B | +5.10% |
| 1997-12-28 | $22.83B | $1.21B | +5.60% |
| 1996-12-29 | $21.62B | $2.78B | +14.74% |
| 1995-12-31 | $18.84B | $3.11B | +19.75% |
| 1995-01-01 | $15.73B | $1.60B | +11.29% |
| 1994-01-02 | $14.14B | $385.00M | +2.80% |
| 1993-01-02 | $13.75B | $1.31B | +10.49% |
| 1992-01-02 | $12.45B | N/A | N/A |
Johnson & Johnson Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.